Envoyer ce communique par e-mail
NANOBIOTIX to Present Positive Results from Its Phase II/III Clinical Trial of NBTXR3 in Patients with Soft Tissue Sarcoma (STS) and Other Ongoing Phase I/II Trials at Upcoming ESMO and ASTRO Annual Conferences
*
Marquer les champs requis
Nom du destinataire:
*
Adresse e-mail du destinataire:
Message:
*
Enter security words: